Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
FDA changes course over shortage of weight-loss drugs
Amid backlash, FDA changes course over shortage of weight-loss drugs
The FDA said Eli Lilly’s weight-loss drugs were no longer in shortage on Oct. 2, preventing pharmacies from making cheaper versions. After an outcry, it’s reconsidering.
FDA will reconsider decision barring copycat versions of Lilly weight loss drug
The Food and Drug Administration (FDA) said it will reconsider its decision to remove Eli Lilly’s blockbuster weight loss and diabetes drug from its official shortage list and allow compounding
Trending weight-loss drug: Is it worth it?
During clinical trials, it became apparent that patients were experiencing significant weight loss. This discovery has led to Semaglutide being prescribed off-label for weight management, although it is not approved by the South African Health Products Regulatory Authority (SAHPRA) for this purpose.
Opinion
Reher: Counterfeit weight-loss drug crisis looms
Bad actors are using online ads, social media and bootleg ingredients to sell fake, inaccurate and harmful versions of these drugs, nearly indistinguishable from the real thing.
FDA shakes up weight loss market as Mounjaro shortage ends
Federal regulators shook up the booming weight loss drug marketplace when they announced Mounjaro and Zepbound were no longer in shortage after nearly two years. Pharmacies that sold unbranded copies of those drugs are mounting a coordinated effort to reverse this decision,
FDA Sparks Controversy With Sudden Removal Of Eli Lilly's Weight Loss Drug From Shortage List
FDA faces legal action after removing Tirzepatide from the shortage list without following required procedures, sparking concerns over patient access to the compounded diabetes and obesity treatment.
Drug makers can’t make knockoff weight-loss drugs anymore—and they’re mad
With the resolution, compounding pharmacies are no longer able to produce tirzepatide. And the FDA highlighted the point to the drug makers, writing in bold that the agency "reminds compounders of the legal restrictions on making copies of FDA-approved drugs."
US FDA to reconsider decision barring compounded versions of Lilly weight loss drug
The U.S. Food and Drug Administration on Friday agreed to reconsider a decision it made last month to bar drug compounders from selling their own versions of Eli Lilly's blockbuster weight loss and diabetes drugs.
How will weight-loss drugs change our relationship with food?
We are now in the era of weight-loss drugs. Decisions on how these drugs will be used look likely to shape our future health and even what our society might look like. And, as researchers are finding,
Weight-loss drugs could reduce risk of overdoses, new study says
A new study suggests that medications like Ozempic could help reduce the risk of overdose and alcohol intoxication in people with substance use disorders.
Rolling Out
1d
Understanding Ozempic: Weight loss, side effects and hair loss concerns
While Ozempic’s weight loss benefits are widely touted, the conversation is increasingly shifting toward its side effects.
6d
on MSN
FDA Reversal on Knockoff GLP-1 Drugs Brings Confusion, and Few Answers
A rapid-fire reversal from the Food and Drug Administration has injected even more uncertainty into what was already a wild ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Liberty win first WNBA title
Advance to World Series
Reaches tentative union deal
Boat rider arrested in FL
Postpones US tour
Trump's Pennsylvania rally
Oscar makes landfall
NYC Halloween dog parade
US probing documents leak
Philip Zimbardo dies at 91
Rock & Roll HOF '24 class
Launches OneWeb mission
Ferry dock collapses in GA
G7 ministers back Ukraine
Urges support for Ukraine
CVS workers strike
New Mexico flash flooding
Opens up on Russian camp
Baldwin returns to 'SNL'
Orionids meteor shower
The Vessel to reopen
Probes near miss in Austin
Oakland fire burns homes
US deficit reaches $1.8T
Antitrust ruling delayed
Opioid suits settlement deal
Wins third PGA Tour title
American activist Wair dies
Hezbollah assets targeted
Albany State shooting
Frozen waffles recalled
Feedback